| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Madrigal Pharmaceuticals, Inc. (MDGL) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 71 sells. MDGL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 452.2K | $241.87M | - | |
| Dir | 205.0K | $109.65M | - | |
| Dir | 200.0K | $106.99M | - | |
| CEO | 150.1K | $80.27M | - | |
| Dir | 29.7K | $15.88M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Friedman Paul A | Director | Sale+OE | 46,808 | $355.31 | $16,631,386.12 | -1.9% | +38.1% | - | |
| Aug 12, 2025 | Taub Rebecca | Director | Sale+OE | 46,463 | $355.32 | $16,509,031.65 | -0.8% | +38.1% | - | |
| Jul 18, 2025 | Taub Rebecca | Director | Sale+OE | 1,000 | $350.01 | $350,005.00 | -0.2% | +32.3% | - | |
| Jul 18, 2025 | Friedman Paul A | Director | Sale+OE | 1,400 | $350.03 | $490,043.96 | -0.7% | +32.3% | - | |
| Jul 17, 2025 | Taub Rebecca | Director | Sale+OE | 29,101 | $353.19 | $10,278,098.16 | -0.7% | +24.3% | - | |
| Jul 17, 2025 | Friedman Paul A | Director | Sale+OE | 28,876 | $353.19 | $10,198,844.04 | -1.6% | +24.3% | - | |
| Mar 13, 2025 | Craves Fred B | Director | Sale+OE | 15,470 | $328.54 | $5,082,479.62 | -0.3% | -8.9% | +37.7% | |
| Mar 10, 2025 | Dier Mardi70 | SVP And CFO | Sell | 258 | $323.04 | $83,344.32 | -2.4% | -14.9% | +31.5% | |
| Mar 5, 2025 | Waltermire Robert E.48 | Senior VP, Chief Pharma Dev. | Sale+OE | 14,113 | $341.32 | $4,817,103.60 | -12.2% | -18.1% | +26.6% | |
| Mar 3, 2025 | Huntsman Carole | Chief Commercial Officer | Sell | 771 | $319.03 | $245,969.68 | -1.9% | -13.0% | +35.9% |